Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,718 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockers.
Konoshita T, Makino Y, Kimura T, Fujii M, Morikawa N, Wakahara S, Arakawa K, Inoki I, Nakamura H, Miyamori I; Genomic Disease Outcome Consortium (G-DOC) Study Investigators. Konoshita T, et al. Among authors: fujii m. Int J Cardiol. 2013 Jun 20;166(2):448-52. doi: 10.1016/j.ijcard.2011.10.133. Epub 2011 Nov 21. Int J Cardiol. 2013. PMID: 22112682 Clinical Trial.
A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker.
Konoshita T, Makino Y, Kimura T, Fujii M, Wakahara S, Arakawa K, Inoki I, Nakamura H, Miyamori I; Genomic Disease Outcome Consortium Study Investigators. Konoshita T, et al. Among authors: fujii m. J Hypertens. 2010 Oct;28(10):2156-60. doi: 10.1097/HJH.0b013e32833d01dd. J Hypertens. 2010. PMID: 20625317 Clinical Trial.
On the top of ARB N/L type Ca channel blocker leads to less elevation of aldosterone.
Konoshita T, Kaeriyama S, Urabe M, Nakaya T, Yamada M, Ichikawa M, Yamamoto K, Sato S, Imagawa M, Fujii M, Makino Y, Zenimaru Y, Wakahara S, Suzuki J, Ishizuka T, Nakamura H; Genomic Disease Outcome Consortium (G-DOC) Study Investigators. Konoshita T, et al. Among authors: fujii m. Biosci Rep. 2016 Sep 16;36(5):e00381. doi: 10.1042/BSR20160129. Print 2016 Oct. Biosci Rep. 2016. PMID: 27515419 Free PMC article.
Aldosterone inhibits endothelial morphogenesis and angiogenesis through the downregulation of vascular endothelial growth factor receptor-2 expression subsequent to peroxisome proliferator-activated receptor gamma.
Fujii M, Inoki I, Saga M, Morikawa N, Arakawa K, Inaba S, Yoshioka K, Konoshita T, Miyamori I. Fujii M, et al. J Steroid Biochem Mol Biol. 2012 Apr;129(3-5):145-52. doi: 10.1016/j.jsbmb.2011.12.014. Epub 2011 Dec 28. J Steroid Biochem Mol Biol. 2012. PMID: 22212769
Differential effects of α-glucosidase inhibitors on postprandial plasma glucose and lipid profile in patients with type 2 diabetes under control with insulin lispro mix 50/50.
Kimura T, Suzuki J, Ichikawa M, Imagawa M, Sato S, Fujii M, Zenimaru Y, Inaba S, Takahashi S, Konoshita T, Miyamori I. Kimura T, et al. Among authors: fujii m. Diabetes Technol Ther. 2012 Jul;14(7):545-51. doi: 10.1089/dia.2012.0015. Epub 2012 Apr 20. Diabetes Technol Ther. 2012. PMID: 22519736 Clinical Trial.
Determinants of plasma renin activity: role of a human renin gene variant as a genetic factor.
Konoshita T, Nakaya T, Sakai A, Yamada M, Ichikawa M, Sato S, Imagawa M, Fujii M, Yamamoto K, Makino Y, Arakawa K, Suzuki J, Ishizuka T; Genomic Disease Outcome Consortium (G-DOC) Study Investigators. Konoshita T, et al. Among authors: fujii m. Medicine (Baltimore). 2014 Dec;93(29):e354. doi: 10.1097/MD.0000000000000354. Medicine (Baltimore). 2014. PMID: 25546694 Free PMC article.
Genetic variant of the renin-angiotensin system and prevalence of type 2 diabetes mellitus: a modest but significant effect of aldosterone synthase.
Ichikawa M, Konoshita T, Nakaya T, Yamamoto K, Yamada M, Sato S, Imagawa M, Makino Y, Fujii M, Zenimaru Y, Arakawa K, Suzuki J, Ishizuka T, Nakamura H. Ichikawa M, et al. Among authors: fujii m. Acta Diabetol. 2014 Aug;51(4):595-9. doi: 10.1007/s00592-014-0561-7. Epub 2014 Feb 19. Acta Diabetol. 2014. PMID: 24549414 Free PMC article.
Comparative effects of insulin glulisine and lispro on postprandial plasma glucose and lipid profile in Japanese patients with type 2 diabetes mellitus.
Yamada M, Suzuki J, Nakaya T, Ichikawa M, Yamamoto K, Imagawa M, Sato S, Fujii M, Zenimaru Y, Konoshita T, Ishizuka T. Yamada M, et al. Among authors: fujii m. Diabetol Int. 2020 Nov 17;12(3):330-335. doi: 10.1007/s13340-020-00475-1. eCollection 2021 Jul. Diabetol Int. 2020. PMID: 34150441 Free PMC article.
3,718 results